Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

NCT ID: NCT01470612

Last Updated: 2021-09-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

944 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-01

Study Completion Date

2020-08-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP-690,550.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CP-690,550 5 mg BID

5 mg BID

Group Type EXPERIMENTAL

CP-690,550

Intervention Type DRUG

5 mg tablets, BID, for at least 12 months

CP-690,550 10 mg BID

10 mg BID

Group Type EXPERIMENTAL

CP-690,550

Intervention Type DRUG

10 mg tablets, BID, for at least 12 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CP-690,550

5 mg tablets, BID, for at least 12 months

Intervention Type DRUG

CP-690,550

10 mg tablets, BID, for at least 12 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who completed induction studies A3921094 or A3921095 and were classified as not meeting clinical response criteria; OR
* Subjects who completed maintenance study A3921096 or who discontinued treatment early in Study A3921096 due to treatment failure.

Exclusion Criteria

* Subjects who had a major protocol violation in Study A3921094, A3921095 or A3921096.
* Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.
* Subjects who have had surgery for ulcerative colitis or in the opinion of the investigator, are likely to require surgery for ulcerative colitis during the study period.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alabama Medical Group, P.C.

Mobile, Alabama, United States

Site Status

Desert Sun Clinical Research, LLC

Tucson, Arizona, United States

Site Status

Desert Sun Gastroenterology

Tucson, Arizona, United States

Site Status

Desert Sun Surgery Center

Tucson, Arizona, United States

Site Status

Altman Clinical and Translational Research Institute

La Jolla, California, United States

Site Status

Perlman Medical Offices - UC San Diego Health System

La Jolla, California, United States

Site Status

UCSD Medical Center

La Jolla, California, United States

Site Status

Cedars Sinai Medical Center

Los Angeles, California, United States

Site Status

Cedars Sinai Surgery Center

Los Angeles, California, United States

Site Status

Alliance Clinical Research

Oceanside, California, United States

Site Status

Center for Endoscopy- Covenant Surgical Partners

Oceanside, California, United States

Site Status

Sharp Rees-Stealy Medical Group, Inc.

San Diego, California, United States

Site Status

Clinical Applications Laboratories, Inc

San Diego, California, United States

Site Status

Sharp Rees-Stealy Medical Group

San Diego, California, United States

Site Status

UCSF Center for Colitis and Crohn's Disease

San Francisco, California, United States

Site Status

Connecticut Clinical Research Institute

Bristol, Connecticut, United States

Site Status

Endoscopy Center of Connecticut, LLC

Guilford, Connecticut, United States

Site Status

Endoscopy Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Gastroenterology Center of Connecticut, PC

Hamden, Connecticut, United States

Site Status

Medical Research Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Yale New Haven Hospital

New Haven, Connecticut, United States

Site Status

Yale University School of Medicine

New Haven, Connecticut, United States

Site Status

Nature Coast Clinical Research

Inverness, Florida, United States

Site Status

North Florida Gastroenterology Research, LLC

Orange Park, Florida, United States

Site Status

Citrus Ambulatory Surgery Center

Orlando, Florida, United States

Site Status

Internal Medicine Specialists

Orlando, Florida, United States

Site Status

Advanced Gastroenterology Center

Port Orange, Florida, United States

Site Status

Advanced Medical Research Center

Port Orange, Florida, United States

Site Status

Endoscopy Center

Port Orange, Florida, United States

Site Status

Port Orange Urgent Care

Port Orange, Florida, United States

Site Status

Florida Medical Clinic, P.A.

Zephyrhills, Florida, United States

Site Status

Atlanta Center for Gastroenterology, P.C.

Decatur, Georgia, United States

Site Status

Gastroenterology Associates of Central Georgia, LLC

Macon, Georgia, United States

Site Status

Atlanta Gastroenterology Specialists, PC

Suwanee, Georgia, United States

Site Status

Cotton O'Neil Clinical Research Center, Digestive Health

Topeka, Kansas, United States

Site Status

Digestive Disease Associates, PA

Catonsville, Maryland, United States

Site Status

Gastrointestinal Diagnostic Center

Catonsville, Maryland, United States

Site Status

MGG Group Co., Inc., Chevy Chase Clinical Research

Chevy Chase, Maryland, United States

Site Status

Howard County GIDC

Columbia, Maryland, United States

Site Status

East Ann Arbor Health and Geriatrics Center -UMHS

Ann Arbor, Michigan, United States

Site Status

Michigan Clinical Research Unit - UMHS

Ann Arbor, Michigan, United States

Site Status

Medical Science Research Building 1 - UMHS

Ann Arbor, Michigan, United States

Site Status

University of Michigan Health Systems

Ann Arbor, Michigan, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Center for Digestive Health

Troy, Michigan, United States

Site Status

Surgical Centers of Michigan

Troy, Michigan, United States

Site Status

Huron Gastroenterology Associates - Center for Digestive Care

Ypsilanti, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

AGA Clinical Research Associates, LLC

Egg Harbor, New Jersey, United States

Site Status

South Jersey Gastroenterology, P.A.

Marlton, New Jersey, United States

Site Status

The Gastroenterology Group of South Jersey

Vineland, New Jersey, United States

Site Status

NYU Langone Long Island Clinical Research Associates

Lake Success, New York, United States

Site Status

IBD Center - The Mount Sinai Hospital

New York, New York, United States

Site Status

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Site Status

Columbia University Irving Medical Center

New York, New York, United States

Site Status

Kornbluth, Legnani, George MD, PC

New York, New York, United States

Site Status

University of Rochester

Rochester, New York, United States

Site Status

Carolina Research, Carolina Digestive Diseases

Greenville, North Carolina, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Great Lakes Gastroenterology Research, LLC

Mentor, Ohio, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Texas Clinical Research Institute

Arlington, Texas, United States

Site Status

Baylor College of Medicine- Baylor Medical Center

Houston, Texas, United States

Site Status

McGovern Medical School -The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Memorial Hermann Hospital

Houston, Texas, United States

Site Status

Tyler Research Institute, LLC

Tyler, Texas, United States

Site Status

Alpine Medical Group

Salt Lake City, Utah, United States

Site Status

Salt Lake Regional Hospital

Salt Lake City, Utah, United States

Site Status

Wasatch Clinical Research

Salt Lake City, Utah, United States

Site Status

VCU Health System Digestive Health Center

Richmond, Virginia, United States

Site Status

VCU Health System Endoscopy Suite

Richmond, Virginia, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

Center for Digestive Health

Milwaukee, Wisconsin, United States

Site Status

Wisconsin Center for Advanced Research - a division of GI Associates, LLC

Milwaukee, Wisconsin, United States

Site Status

The Canberra Hospital

Garran, Australian Capital Territory, Australia

Site Status

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Nepean Hospital

Kingswood, New South Wales, Australia

Site Status

Liverpool Hospital eastern Campus

Liverpool, New South Wales, Australia

Site Status

Eastern Health, Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

Gastroenterology and Hepatology Unit

Clayton, Victoria, Australia

Site Status

Landeskrankenhaus Innsbruck

Innsbruck, , Austria

Site Status

Krankenhaus Barmherzige Brueder St. Veit/Glan

Sankt Veit an der Glan, , Austria

Site Status

AKH Wien, Universitaetsklinik fuer Innere Medizin III

Vienna, , Austria

Site Status

GZA St Vincentius

Antwerp, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

UZ Leuven (University Hospital Leuven), Campus Gasthuisberg

Leuven, , Belgium

Site Status

H-Hartziekenhuis Roeselare-Menen vzw

Roeselare, , Belgium

Site Status

Hospital de Clinicas de Porto Alegre - HCPA

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

University of Calgary, Heritage Medical Research Clinic, TRW Building

Calgary, Alberta, Canada

Site Status

University of Alberta Hospital - Walter C. Mackenzie Health Sciences Centre

Edmonton, Alberta, Canada

Site Status

University of Alberta - Zeidler Ledcor Centre

Edmonton, Alberta, Canada

Site Status

McMaster University Medical Center

Hamilton, Ontario, Canada

Site Status

London Health Sciences Centre - University Hospital

London, Ontario, Canada

Site Status

Hopital Maisonneuve-Rosemont/Pavillon Rachel-Tourigny

Montreal, Quebec, Canada

Site Status

Montreal General Hospital - McGill University Health Care Centre

Montreal, Quebec, Canada

Site Status

Saskatoon City Hospital

Saskatoon, Saskatchewan, Canada

Site Status

Royal University Hospital

Saskatoon, Saskatchewan, Canada

Site Status

Instituto de Coloproctologia ICO S.A.S.

Medellín, Antioquia, Colombia

Site Status

University Hospital Center Zagreb

Zagreb, , Croatia

Site Status

Hepato-Gastroenterologie HK, s.r.o.

Hradec Králové, , Czechia

Site Status

Klinicke Centrum ISCARE I.V.F., Gastroenterologie

Prague, , Czechia

Site Status

Nemocnice Strakonice, a.s., Interni oddeleni

Strakonice, , Czechia

Site Status

Krajska Zdravotni, A.S.,

Ústí nad Labem, , Czechia

Site Status

Bispebjerg Hospital

Copenhagen, NV, Denmark

Site Status

Aalborg Hospital

Aalborg, , Denmark

Site Status

Aarhus University Hospital

Aarhus C, , Denmark

Site Status

Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Odense University Hospital

Odense C, , Denmark

Site Status

West Tallinn Central Hospital

Tallinn, Harju, Estonia

Site Status

Innomedica OU

Tallinn, , Estonia

Site Status

CHU Amiens-Picardie - Hopital Sud

Amiens, , France

Site Status

Hopital Beaujon, Gastroenterologie, MICI et Assistance Nutritive

Clichy, , France

Site Status

CHU de Nantes - Hotel Dieu-Service d'Hepato-Gastroenterologie

Nantes, , France

Site Status

Hôpital Saint Louis - Service d'hepato-gastroenterologie

Paris, , France

Site Status

Hôpital Saint Louis

Paris, , France

Site Status

Hopital Saint Antoine - Service de Gastroenterologie

Paris, , France

Site Status

Hopital Haut-Leveque-CMC Magellan- Unite de Recherche Clinique

Pessac, , France

Site Status

CHU de Reims - Hopital Robert Debre

Reims, , France

Site Status

Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

Hopital Rangueil

Toulouse, , France

Site Status

Universitatsklinikum Schleswig-Holstein, Campus Kiel

Kiel, Schlewig Holstein, Germany

Site Status

Universitaetsmedizin Berlin, Charite Campus Virchow-Klinikum, Medizinische Klinik mit

Berlin, , Germany

Site Status

Universitaesklinikum Halle, Klinik und Poliklinik fuer Innere Medizin I

Halle, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Klinikum Lüneburg

Lüneburg, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Minden

Minden, , Germany

Site Status

University Hospital Munich-Grosshadern

Munich, , Germany

Site Status

Universitaetsklinikum Ulm

Ulm, , Germany

Site Status

Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaza; III. Belgyogyaszat - Gasztroenterologia'.

Békéscsaba, , Hungary

Site Status

Peterfy Sandor utcai Korhaz-Rendelointezet es Manninger Jeno Orszagos Traumatologiai Intezet

Budapest, , Hungary

Site Status

Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak I Belgyogyaszati-Gasztroenterologiai Osztaly

Budapest, , Hungary

Site Status

Pannonia Maganorvosi Centrum Kft.

Budapest, , Hungary

Site Status

Szent Margit Kórház, III. Belgyógyászati-Gasztroenterológiai Osztály

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza III.sz. Belgyoyaszat Gasztroenterologia

Gyula, , Hungary

Site Status

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz

Miskolc, , Hungary

Site Status

Karolina Korhaz

Mosonmagyaróvár, , Hungary

Site Status

Pecsi Tudomanyegyetem Klinikai Kozpont

Pécs, , Hungary

Site Status

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, I. Sz. Belgyogyaszati Klinika

Szeged, , Hungary

Site Status

Javorszky Odon Korhaz

Vác, , Hungary

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

The Edith Wolfson Medical Center/Gastroenterology Department

Holon, , Israel

Site Status

Rabin Medical Center, Beilinson campus

Petah Tikva, , Israel

Site Status

Istituto Clinico Humanitas IRCCS-IBD Center

Rozzano, Milano, Italy

Site Status

AOR Villa Sofia-Cervello

Palermo, PA, Italy

Site Status

AOU Mater Domini - U.O. Fisiopatologia Digestiva

Catanzaro, , Italy

Site Status

Aichi Medical University Hospital

Nagakute, Aichi-ken, Japan

Site Status

National Hospital Organization Hirosaki National Hospital

Hirosaki, Aomori, Japan

Site Status

Toho University Sakura Medical Center

Sakura, Chiba, Japan

Site Status

Kurume University Hospital

Kurume, Fukuoka, Japan

Site Status

Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

Sapporo, Hokkaido, Japan

Site Status

National Hospital Organization Mito Medical Center

Higashi-ibaraki-gun, Ibaraki, Japan

Site Status

Sameshima Hospital

Kagoshima, Kagoshima-ken, Japan

Site Status

Kuniyoshi Hospital

Kochi, Kochi, Japan

Site Status

National Hospital Organization Sendai Medical Center

Sendai, Miyagi, Japan

Site Status

Osaka City University Hospital

Osaka, Osaka, Japan

Site Status

Osaka Medical College Hospital

Takatsuki-shi, Osaka, Japan

Site Status

Shiga University of Medical Science Hospital

Ōtsu, Shiga, Japan

Site Status

Tokyo Medical And Dental University Hospital, Faculty of Medicine

Bunkyo-ku, Tokyo, Japan

Site Status

Tokai University Hachioji Hospital

Hachiōji, Tokyo, Japan

Site Status

Jikei University Hospital

Minato-ku, Tokyo, Japan

Site Status

Kitasato University Kitasato Institute Hospital

Minato-ku, Tokyo, Japan

Site Status

Keio University Hospital

Shinjuku-ku, Tokyo, Japan

Site Status

Fukuoka University Chikushi Hospital

Fukuoka, , Japan

Site Status

Hiroshima University Hospital

Hiroshima, , Japan

Site Status

The Hospital of Hyogo College of Medicine

Hyōgo, , Japan

Site Status

Showa University Hospital

Tokyo, , Japan

Site Status

Digestive Diseases Center GASTRO

Riga, , Latvia

Site Status

VU University Medical Center

Amsterdam, , Netherlands

Site Status

Academic Medical Center (AMC)

Amsterdam, , Netherlands

Site Status

University Medical Center Groningen (UMCG)

Groningen, , Netherlands

Site Status

Leiden University Medical Center

Leiden, , Netherlands

Site Status

Clinical Trials Unit- Tauranga Hospital-Bay of Plenty (BOP) Clinical School

Tauranga, Bay of Plenty, New Zealand

Site Status

Christchurch Hospital

Christchurch, Canterbury, New Zealand

Site Status

North Shore Hospital (Waitemata District Health Board)

Auckland, , New Zealand

Site Status

Auckland City Hospital

Auckland, , New Zealand

Site Status

Southern District Health Board

Dunedin, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

P3 Research Limited

Wellington, , New Zealand

Site Status

Centrum Medyczne Szpital Sw. Rodziny Sp. z o. o.

Lodz, Iodzkie, Poland

Site Status

Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Gabinet Lekarski - Janusz Rudzinski

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Klinika Chorob Wewnetrznych i Gastroenterologii z Pododdzialem Leczenia Nieswoistych Chorob

Warsaw, Masovian Voivodeship, Poland

Site Status

Oddzial Chorob Wewnetrznych i Gastroenterologii, SP ZOZ Wojewodzki Szpital

Bialystok, Podlaskie Voivodeship, Poland

Site Status

H-T. Centrum Medyczne - ENDOTERAPIA

Tychy, Silesian Voivodeship, Poland

Site Status

Gabinet Endoskopii Przewodu Pokarmowego

Krakow, , Poland

Site Status

Oddzial Kliniczny Gastroenterologii Ogolnej i Onkologicznej, Uniwersytecki Szpital Kliniczny nr

Lodz, , Poland

Site Status

Endoskopia SP. Z O.O.

Sopot, , Poland

Site Status

NZOZ Vivamed

Warsaw, , Poland

Site Status

Lexmedica

Wroclaw, , Poland

Site Status

Cabinet Particular Policlinic Algomed SRL

Timișoara, Timiș County, Romania

Site Status

Spitalul Universitar de Urgenta Bucharest, Medicina Interna II Gastroenterologie

Bucharest, , Romania

Site Status

Federal State Budgetary Institution "State Scientific Centre of Coloproctology n.a. A.N. Ryzhikh"

Moscow, , Russia

Site Status

State budget Healthcare Institution Moscow regional scientific research clinical institute

Moscow, , Russia

Site Status

State budget Institution of Healthcare Nizhniy Novgorod Regional Clinical Hospital named after N. A.

Nizhny Novgorod, , Russia

Site Status

Municipal Budget Institution of Healthcare of Novosibirsk

Novosibirsk, , Russia

Site Status

Federal State Budgetary Institution Scientific Research Institute of Physiology and Fundamental

Novosibirsk, , Russia

Site Status

FSBI "Scientific Research Institute of Physiology and Fundamental Medicine"

Novosibirsk, , Russia

Site Status

Non-State Healthcare Institution "Road Clinical Hospital at the station Samara"

Samara, , Russia

Site Status

Limited Liability Company Medical Company "Hepatolog"

Samara, , Russia

Site Status

Samara Diagnostic center, X-ray Department

Samara, , Russia

Site Status

State budget institution of healthcare of Yaroslavl region Regional clinical hospital

Yaroslavl, , Russia

Site Status

Military Medical Academy

Belgrade, Central Serbia, Serbia

Site Status

Clinical Centre of Serbia Clinic for Gastroenterology and Hepatology

Belgrade, , Serbia

Site Status

Clinical Hospital Center Zvezdara - Clinic for Gastroenterology and Hepatology

Belgrade, , Serbia

Site Status

Clinical Centre of Kragujevac Clinic for Gastroenterology and Hepatology

Kragujevac, , Serbia

Site Status

Clinical Centre of Vojvodina Emergency Internal Medicine Division

Novi Sad, , Serbia

Site Status

Clinical Centre of Vojvodina, Clinic for Gastroenterology and Hepatology

Novi Sad, , Serbia

Site Status

General Hospital Djordje Joanovic

Zrenjanin, , Serbia

Site Status

Medak s.r.o.

Bratislava, , Slovakia

Site Status

"KM Management spol. s.r.o.Gastroenterologicke a hepatologicke centrum Nitra

Nitra, , Slovakia

Site Status

Poliklinika Libris, Synergy group, a.s.,

Nové Mesto nad Váhom, , Slovakia

Site Status

Gastro I., s.r.o.

Prešov, , Slovakia

Site Status

Chris Hani Baragwanath Academic Hospital

Johannesburg, Gauteng, South Africa

Site Status

Panorama Medi-Clinic

Cape Town, Western Cape, South Africa

Site Status

Louis Leipoldt Medical Centre

Cape Town, Western Cape, South Africa

Site Status

Dr JP Wright

Cape Town, Western Cape, South Africa

Site Status

Endocare Research Centre

Paarl, Western Cape, South Africa

Site Status

Hanyang University Guri Hospital

Guri-si, Gyeonggi-do, South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital,

Seoul, , South Korea

Site Status

Severance Hospital, Yonsei University Health System

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Hospital Universitario de Fuenlabrada

Fuenlabrada, Madrid, Spain

Site Status

Hospital Clinic i Provincial de Barcelona

Barcelona, , Spain

Site Status

Corporacio Sanitaria Parc Tauli

Barcelona, , Spain

Site Status

Hospital Universitario de La Princesa

Madrid, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Regional Municipal Institution "Chernivtsi Regional Clinical Hospital"

Chernivtsi, , Ukraine

Site Status

Regional Municipal Institution 'Chernivtsi Regional Clinical Hospital'

Chernivtsi, , Ukraine

Site Status

SI 'Institute of Gastroenterology of the NAMS of Ukraine', Dep.-nt of Stomach and Duodenum diseases

Dnipropetrovsk, , Ukraine

Site Status

Municipal Healthcare Institution Kharkiv City Clinical Hospital #2

Kharkiv, , Ukraine

Site Status

State Institution "L.T. Malaya Therapy Institute of NAMS of Ukraine"

Kharkiv, , Ukraine

Site Status

Kyiv Municipal Clinical Hospital #18, Proctology Department

Kyiv, , Ukraine

Site Status

LTD "St. Paraskeva Medical Center"

Lviv, , Ukraine

Site Status

Municipal City Clinical Hospital of the Emergency Medical Care, 1-st Therapy Department of hospital,

Lviv, , Ukraine

Site Status

Municipal Institution "Odesa Regional Clinical Hospital", polyclinic department

Odesa, , Ukraine

Site Status

"Odesa Clinical Hospital for Railway ""Branch of ""Healthcare center of Private JSC ""Ukrainian

Odesa, , Ukraine

Site Status

CI of Uzhgorod Regional Rada Uzhgorod Central Regional Hospital". Therapy Department. SHEI Uzhgorod

Uzhhorod, , Ukraine

Site Status

Vinnytsia Regional Clinical Hospital for War Veterans, Therapeutics Dept. No. 2

Vinnytsia, , Ukraine

Site Status

Minicipal Institution City Hospital #7, Therapeutic Department,

Zaporizhzhia, , Ukraine

Site Status

Bristol Royal Infirmary

Bristol, England, United Kingdom

Site Status

Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust

Cambridge, England, United Kingdom

Site Status

The North West London Hospitals NHS Trust

Harrow, Middlesex, United Kingdom

Site Status

Norfolk and Norwich University Hospitals NHS Foundation Trust

Norwich, Norfolk, United Kingdom

Site Status

UCLH NIHR Clinical Research Facility

London, W1T 7HA, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Brazil Canada Colombia Croatia Czechia Denmark Estonia France Germany Hungary Israel Italy Japan Latvia Netherlands New Zealand Poland Romania Russia Serbia Slovakia South Africa South Korea Spain Taiwan Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Panes J, D'Haens GR, Sands BE, Ng SC, Lawendy N, Kulisek N, Guo X, Wu J, Vranic I, Panaccione R, Vermeire S. Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure. United European Gastroenterol J. 2024 Jul;12(6):793-801. doi: 10.1002/ueg2.12584. Epub 2024 May 22.

Reference Type DERIVED
PMID: 38778549 (View on PubMed)

Rubin DT, Torres J, Regueiro M, Reinisch W, Prideaux L, Kotze PG, Tan FH, Gardiner S, Mundayat R, Cadatal MJ, Ng SC. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohns Colitis 360. 2024 Jan 20;6(1):otae004. doi: 10.1093/crocol/otae004. eCollection 2024 Jan.

Reference Type DERIVED
PMID: 38425446 (View on PubMed)

Rubin DT, Salese L, Cohen M, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD. Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program. Therap Adv Gastroenterol. 2023 Aug 7;16:17562848231189122. doi: 10.1177/17562848231189122. eCollection 2023.

Reference Type DERIVED
PMID: 37560161 (View on PubMed)

Schreiber S, Rubin DT, Ng SC, Peyrin-Biroulet L, Danese S, Modesto I, Guo X, Su C, Kwok KK, Jo H, Chen Y, Yndestad A, Reinisch W, Dubinsky MC. Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24;17(11):1761-1770. doi: 10.1093/ecco-jcc/jjad104.

Reference Type DERIVED
PMID: 37402275 (View on PubMed)

Kristensen LE, Danese S, Yndestad A, Wang C, Nagy E, Modesto I, Rivas J, Benda B. Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance. Ann Rheum Dis. 2023 Jul;82(7):901-910. doi: 10.1136/ard-2022-223715. Epub 2023 Mar 17.

Reference Type DERIVED
PMID: 36931693 (View on PubMed)

Winthrop KL, Yndestad A, Henrohn D, Danese S, Marsal S, Galindo M, Woolcott JC, Jo H, Kwok K, Shapiro AB, Jones TV, Diehl A, Su C, Panes J, Cohen SB. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatol Ther. 2023 Apr;10(2):357-373. doi: 10.1007/s40744-022-00507-z. Epub 2022 Dec 17.

Reference Type DERIVED
PMID: 36526796 (View on PubMed)

Lichtenstein GR, Bressler B, Francisconi C, Vermeire S, Lawendy N, Salese L, Sawyerr G, Shi H, Su C, Judd DT, Jones T, Loftus EV. Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2023 Jan 5;29(1):27-41. doi: 10.1093/ibd/izac084.

Reference Type DERIVED
PMID: 36342120 (View on PubMed)

Hudesman DP, Torres J, Salese L, Woolcott JC, Mundayat R, Su C, Mosli MH, Allegretti JR. Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program. Patient. 2023 Mar;16(2):95-103. doi: 10.1007/s40271-022-00603-w. Epub 2022 Nov 7.

Reference Type DERIVED
PMID: 36336750 (View on PubMed)

Biedermann L, Dubinsky MC, Vermeire S, Fellmann M, Gardiner S, Hur P, Mundayat R, Panes J, Rubin DT. Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2023 Sep 1;29(9):1370-1379. doi: 10.1093/ibd/izac222.

Reference Type DERIVED
PMID: 36242764 (View on PubMed)

Sandborn WJ, D'Haens GR, Sands BE, Panaccione R, Ng SC, Lawendy N, Kulisek N, Modesto I, Guo X, Mundayat R, Su C, Vranic I, Panes J. Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme. J Crohns Colitis. 2023 Apr 3;17(3):338-351. doi: 10.1093/ecco-jcc/jjac141.

Reference Type DERIVED
PMID: 36124702 (View on PubMed)

Loftus EV, Baumgart DC, Gecse K, Kinnucan JA, Connelly SB, Salese L, Su C, Kwok KK, Woolcott JC, Armuzzi A. Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program. Inflamm Bowel Dis. 2023 May 2;29(5):744-751. doi: 10.1093/ibd/izac139.

Reference Type DERIVED
PMID: 35792493 (View on PubMed)

Winthrop KL, Vermeire S, Long MD, Panes J, Ng SC, Kulisek N, Mundayat R, Lawendy N, Vranic I, Modesto I, Su C, Melmed GY. Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2023 Jan 5;29(1):85-96. doi: 10.1093/ibd/izac063.

Reference Type DERIVED
PMID: 35648151 (View on PubMed)

Dubinsky MC, Magro F, Steinwurz F, Hudesman DP, Kinnucan JA, Ungaro RC, Neurath MF, Kulisek N, Paulissen J, Su C, Ponce de Leon D, Regueiro M. Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2023 Jan 5;29(1):51-61. doi: 10.1093/ibd/izac061.

Reference Type DERIVED
PMID: 35380664 (View on PubMed)

Feagan BG, Khanna R, Sandborn WJ, Vermeire S, Reinisch W, Su C, Salese L, Fan H, Paulissen J, Woodworth DA, Niezychowski W, Sands BE. Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials. Aliment Pharmacol Ther. 2021 Dec;54(11-12):1442-1453. doi: 10.1111/apt.16626. Epub 2021 Oct 6.

Reference Type DERIVED
PMID: 34614208 (View on PubMed)

Panes J, Vermeire S, Dubinsky MC, Loftus EV, Lawendy N, Wang W, Salese L, Su C, Modesto I, Guo X, Colombel JF. Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials. J Crohns Colitis. 2021 Nov 8;15(11):1852-1863. doi: 10.1093/ecco-jcc/jjab065.

Reference Type DERIVED
PMID: 33884415 (View on PubMed)

Sandborn WJ, Peyrin-Biroulet L, Sharara AI, Su C, Modesto I, Mundayat R, Gunay LM, Salese L, Sands BE. Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status. Clin Gastroenterol Hepatol. 2022 Mar;20(3):591-601.e8. doi: 10.1016/j.cgh.2021.02.043. Epub 2021 Mar 6.

Reference Type DERIVED
PMID: 33684552 (View on PubMed)

Curtis JR, Regueiro M, Yun H, Su C, DiBonaventura M, Lawendy N, Nduaka CI, Koram N, Cappelleri JC, Chan G, Modesto I, Lichtenstein GR. Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data. Inflamm Bowel Dis. 2021 Aug 19;27(9):1394-1408. doi: 10.1093/ibd/izaa289.

Reference Type DERIVED
PMID: 33324993 (View on PubMed)

Sandborn WJ, Peyrin-Biroulet L, Quirk D, Wang W, Nduaka CI, Mukherjee A, Su C, Sands BE. Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1821-1830.e3. doi: 10.1016/j.cgh.2020.10.038. Epub 2020 Oct 27.

Reference Type DERIVED
PMID: 33127596 (View on PubMed)

Colombel JF, Osterman MT, Thorpe AJ, Salese L, Nduaka CI, Zhang H, Lawendy N, Friedman GS, Quirk D, Su C, Reinisch W. Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 Jan;20(1):116-125.e5. doi: 10.1016/j.cgh.2020.10.004. Epub 2020 Oct 9.

Reference Type DERIVED
PMID: 33039585 (View on PubMed)

Sands BE, Colombel JF, Ha C, Farnier M, Armuzzi A, Quirk D, Friedman GS, Kwok K, Salese L, Su C, Taub PR. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflamm Bowel Dis. 2021 May 17;27(6):797-808. doi: 10.1093/ibd/izaa227.

Reference Type DERIVED
PMID: 32870265 (View on PubMed)

Panaccione R, Isaacs JD, Chen LA, Wang W, Marren A, Kwok K, Wang L, Chan G, Su C. Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials. Dig Dis Sci. 2021 Aug;66(8):2732-2743. doi: 10.1007/s10620-020-06560-4. Epub 2020 Aug 20.

Reference Type DERIVED
PMID: 32816215 (View on PubMed)

Lichtenstein GR, Rogler G, Ciorba MA, Su C, Chan G, Pedersen RD, Lawendy N, Quirk D, Nduaka CI, Thorpe AJ, Panes J. Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2021 May 17;27(6):816-825. doi: 10.1093/ibd/izaa199.

Reference Type DERIVED
PMID: 32766762 (View on PubMed)

Sands BE, Armuzzi A, Marshall JK, Lindsay JO, Sandborn WJ, Danese S, Panes J, Bressler B, Colombel JF, Lawendy N, Maller E, Zhang H, Chan G, Salese L, Tsilkos K, Marren A, Su C. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open. Aliment Pharmacol Ther. 2020 Jan;51(2):271-280. doi: 10.1111/apt.15555. Epub 2019 Oct 29.

Reference Type DERIVED
PMID: 31660640 (View on PubMed)

Sandborn WJ, Panes J, Sands BE, Reinisch W, Su C, Lawendy N, Koram N, Fan H, Jones TV, Modesto I, Quirk D, Danese S. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Aliment Pharmacol Ther. 2019 Nov;50(10):1068-1076. doi: 10.1111/apt.15514. Epub 2019 Oct 9.

Reference Type DERIVED
PMID: 31599001 (View on PubMed)

Sands BE, Taub PR, Armuzzi A, Friedman GS, Moscariello M, Lawendy N, Pedersen RD, Chan G, Nduaka CI, Quirk D, Salese L, Su C, Feagan BG. Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Jan;18(1):123-132.e3. doi: 10.1016/j.cgh.2019.04.059. Epub 2019 May 8.

Reference Type DERIVED
PMID: 31077827 (View on PubMed)

Sandborn WJ, Panes J, D'Haens GR, Sands BE, Su C, Moscariello M, Jones T, Pedersen R, Friedman GS, Lawendy N, Chan G. Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1541-1550. doi: 10.1016/j.cgh.2018.11.035. Epub 2018 Nov 23.

Reference Type DERIVED
PMID: 30476584 (View on PubMed)

Winthrop KL, Melmed GY, Vermeire S, Long MD, Chan G, Pedersen RD, Lawendy N, Thorpe AJ, Nduaka CI, Su C. Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

Reference Type DERIVED
PMID: 29850873 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-004581-14

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

OCTAVEOPEN

Identifier Type: OTHER

Identifier Source: secondary_id

A3921139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.